US 7641906
Intranasal immunization with detoxified lipooligosaccharide from nontypeable Haemophilus influenzae or Moraxella catarrhalis
granted A61KA61K2039/543A61K2039/5555
Quick answer
US patent 7641906 (Intranasal immunization with detoxified lipooligosaccharide from nontypeable Haemophilus influenzae or Moraxella catarrhalis) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Dec 31 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Department of Health and Human Services
- Grant date
- Tue Jan 05 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 31 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 25
- CPC classes
- A61K, A61K2039/543, A61K2039/5555, A61K2039/55572, A61K2039/6037